According to a new report from Intel Market Research, the global Respiratory Syncytial Virus Therapeutic Drugs market was valued at USD 1.75 billion in 2025 and is projected to reach USD 3.48 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This growth trajectory is primarily fueled by rising RSV...
English
Indonesia
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek